Article Details

Ozempic short-selling wave storms ASX; CSL, ResMed affected - AFR

Retrieved on: 2023-10-15 19:30:43

Tags for this article:

Click the tags to see associated articles and topics

Ozempic short-selling wave storms ASX; CSL, ResMed affected - AFR. View article details on hiswai:

Excerpt

Morgan Stanley analysts estimate that the US cohort taking anti-obesity medication will increase five-fold over the next decade to 24 million ...

Article found on: www.afr.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up